Authors:
Carlini, P
Frassoldati, A
De Marco, S
Casali, A
Ruggeri, EM
Nardi, M
Papaldo, P
Fabi, A
Paoloni, F
Cognetti, F
Citation: P. Carlini et al., Formestane, a steroidal aromatase inhibitor after failure of non-steroidalaromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?, ANN ONCOL, 12(11), 2001, pp. 1539-1543
Authors:
Nardi, M
De Marco, S
Fabi, A
Aloe, A
Magnani, E
Pacetti, U
Carlini, P
Ruggeri, EM
Cognetti, F
Citation: M. Nardi et al., Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study, CANC CHEMOT, 48(3), 2001, pp. 255-258
Authors:
Catella-Lawson, F
Kapoor, S
Moretti, D
De Marco, S
Vigilante, GJ
Cucchiara, AJ
Ramsey, KE
Combe, S
Rocca, B
Theroux, P
Fitzgerald, GA
Citation: F. Catella-lawson et al., Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease, AM J CARD, 88(3), 2001, pp. 236-242
Authors:
Nistico, C
Garufi, C
Milella, M
Vaccaro, A
D'Ottavio, AM
Fabi, A
Pace, A
Bove, L
Tropea, F
Marsella, A
Izzo, F
D'Attino, RM
Ferraresi, V
De Marco, S
Terzoli, E
Citation: C. Nistico et al., Weekly schedule of vinorelbine in pretreated breast cancer patients, BREAST CANC, 59(3), 2000, pp. 223-229
Authors:
De Marco, S
Fabi, A
Ceribelli, A
Carlini, P
Pollera, CF
Cognetti, F
Citation: S. De Marco et al., Does pain at tumor site during vinorelbine infusion affect treatment of recurrent head and neck cancer patients?, ANN ONCOL, 10(7), 1999, pp. 865-866